title: [MANAGEMENT OF THYMIC EPITHELIAL TUMORS].
abstract: Thymic epithelial tumors (TET) are rare. Their optimal care is still poorly defined because of their rarity and of the resulting difficulty to conceive large clinical trials. This review of the literature presents the current clinical and therapeutic data on this form of tumors and underlines the need for a multidisciplinary approach to advanced stage TET. Three clinical situations can be encountered: encapsuled tumors lead to radical surgery; tumors associated with capsular invasion justify a postoperative radiotherapy; advanced stages require a multimodal treatment by chemotherapy, possibly completed by surgery and adjuvant radiotherapy. Besides systemic chemotherapies, the place of new therapeutic strategies, such as somatostatin analogues and targeted treatments, requires to be defined. Treatment of late stage TET is based upon a multidisciplinary dialogue, ideally by a reference team.
authors: A
authors: A
authors: Paulus
authors: A
authors: A
authors: Sibille
authors: M
authors: M
authors: Bourhaba
authors: M
authors: M
authors: Martin
authors: R
authors: R
authors: Louis
authors: B
authors: B
authors: Duysinx
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000473:pathology* / Q000628:therapy*; D013953:Thymus Neoplasms / Q000473:pathology* / Q000628:therapy*